TRANSMEDICS GROUP INC

NASDAQ: TMDX (TransMedics Group, Inc.)

Last update: yesterday, 9:28PM

82.92

1.99 (2.46%)

Previous Close 80.93
Open 80.81
Volume 797,252
Avg. Volume (3M) 1,494,807
Market Cap 2,782,919,424
Price / Earnings (TTM) 87.28
Price / Earnings (Forward) 64.52
Price / Sales 7.10
Price / Book 13.17
52 Weeks Range
67.77 (-18%) — 177.37 (113%)
Earnings Date 28 Oct 2024
Profit Margin 8.14%
Operating Margin (TTM) 3.61%
Diluted EPS (TTM) 0.930
Quarterly Revenue Growth (YOY) 63.70%
Total Debt/Equity (MRQ) 246.83%
Current Ratio (MRQ) 8.20
Operating Cash Flow (TTM) 23.72 M
Levered Free Cash Flow (TTM) -240.13 M
Return on Assets (TTM) 2.84%
Return on Equity (TTM) 19.41%

Market Trend

Short Term Medium Term
Industry Medical Devices (US) Mixed Mixed
Medical Devices (Global) Mixed Mixed
Stock TransMedics Group, Inc. Bearish Bullish

Stockmoo Score

0.0
Analyst Consensus 2.0
Insider Activity -2.5
Price Volatility 2.0
Technical Moving Averages 1.0
Technical Oscillators -2.5
Average 0.00

Similar Stocks

Stock Market Cap DY P/E P/B
TMDX 3 B - 87.28 13.17
PRCT 5 B - - 20.41
NARI 2 B - - 6.63
IRTC 2 B - - 32.91
RXST 2 B - - 7.39
IRMD 716 M 1.91% 38.68 7.78

TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System(OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The Company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.

Sector Healthcare
Industry Medical Devices
Investment Style Small Growth
% Held by Insiders 3.20%
% Held by Institutions 107.19%

Ownership

Name Date Shares Held
Driehaus Capital Management Llc 30 Sep 2024 1,442,207
Credit Suisse Ag/ 31 Mar 2024 847,885
Fil Ltd 30 Sep 2024 781,397
Eventide Asset Management, Llc 30 Sep 2024 690,632
Allspring Global Investments Holdings, Llc 30 Sep 2024 599,116
52 Weeks Range
67.77 (-18%) — 177.37 (113%)
Price Target Range
104.00 (25%) — 180.00 (117%)
High 180.00 (Piper Sandler, 117.08%) Buy
Median 120.00 (44.72%)
Low 104.00 (Canaccord Genuity, 25.42%) Buy
Average 129.14 (55.74%)
Total 7 Buy
Avg. Price @ Call 86.62
Firm Date Target Price Call Price @ Call
Canaccord Genuity 20 Nov 2024 104.00 (25.42%) Buy 82.92
29 Oct 2024 109.00 (31.45%) Buy 88.50
TD Cowen 18 Nov 2024 120.00 (44.72%) Buy 80.93
Baird 29 Oct 2024 150.00 (80.90%) Buy 88.50
24 Sep 2024 200.00 (141.20%) Buy 156.00
JP Morgan 29 Oct 2024 116.00 (39.89%) Buy 88.50
Needham 29 Oct 2024 109.00 (31.45%) Buy 88.50
23 Aug 2024 208.00 (150.84%) Buy 175.66
Oppenheimer 29 Oct 2024 125.00 (50.75%) Buy 88.50
Piper Sandler 29 Oct 2024 180.00 (117.08%) Buy 88.50
07 Oct 2024 180.00 (117.08%) Buy 134.11
Show more
Name Avg. Buy ($) Avg. Sell ($) Net Quantity Net Value ($)
KHAYAL TAMER I - 89.11 -1,458 -129,922
Aggregate Net Quantity -1,458
Aggregate Net Value ($) -129,922
Aggregate Avg. Buy ($) -
Aggregate Avg. Sell ($) 89.11
Name Holder Date Type Quantity Price Value ($)
KHAYAL TAMER I Officer 11 Nov 2024 Automatic sell (-) 1,458 89.11 129,922
KHAYAL TAMER I Officer 11 Nov 2024 Option execute 1,458 - -

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2024 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria